Nuvation Bio gets $250M total funding for taletrectinib commercialization & pipeline; Syros to delist from Nasdaq on March 20 after January compliance warning ...
ASUS has just introduced their new Radeon RX 9070 and 9070 XT graphics cards, utilising AMD’s RDNA 4 architecture. While we ...
As spotted by Neowin, two of the most recent Windows 11 24H2 patches (KB5050094 and KB5051987) have caused crashing and ...
The US Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation for Anktiva ...
D. Boral Capital reaffirmed their buy rating on shares of ImmunityBio (NASDAQ:IBRX – Free Report) in a research report released on Friday,Benzinga reports. The firm currently has a $30.00 target price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results